This grant is dedicated to fostering the development of groundbreaking technologies designed to revolutionize the delivery of critical substances. Its core objective is to significantly enhance the transportation of pharmacological agents, gene editing tools, and other vital cargoes. The research specifically targets applications within HIV (Human Immunodeficiency Virus) and SUD (Substance Use Disorder) studies. This encompasses both mechanistic investigations, aimed at deciphering fundamental biological processes, and therapeutic research, focused on creating novel treatments. By advancing these delivery methods, the grant seeks to enable more precise, efficient, and impactful interventions, ultimately accelerating progress in understanding and combating HIV and SUD, and improving patient outcomes through innovative therapeutic approaches.
Opportunity ID: 350820
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-25-022 |
| Funding Opportunity Title: | Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 01, 2023 |
| Last Updated Date: | Nov 01, 2023 |
| Original Closing Date for Applications: | Nov 15, 2024 |
| Current Closing Date for Applications: | Nov 15, 2024 |
| Archive Date: | Dec 21, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Independent school districts Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD or mechanistic or therapeutic research |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350820 Full Announcement-RFA-DA-25-022 -> RFA-DA-25-022-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283668 | Oct 15, 2024 | Nov 15, 2024 | View |
Package 1
Mandatory forms
350820 RR_SF424_5_0-5.0.pdf
350820 PHS398_CoverPageSupplement_5_0-5.0.pdf
350820 RR_OtherProjectInfo_1_4-1.4.pdf
350820 PerformanceSite_4_0-4.0.pdf
350820 RR_KeyPersonExpanded_4_0-4.0.pdf
350820 PHS398_ResearchPlan_5_0-5.0.pdf
350820 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350820 RR_Budget_3_0-3.0.pdf
350820 RR_SubawardBudget30_3_0-3.0.pdf
350820 PHS398_ModularBudget_1_2-1.2.pdf
350820 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
